Comparison of hyperglycemia, hypertension, and hypercholesterolemia management in patients with type 2 diabetes

被引:74
作者
Grant, RW
Cagliero, E
Murphy-Sheehy, P
Singer, DE
Nathan, DM
Meigs, JB
机构
[1] Massachusetts Gen Hosp, Gen Med Div, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Dept Med, Div Gen Med, Boston, MA USA
[3] Harvard Univ, Sch Med, Dept Med, Clin Res Program, Boston, MA USA
[4] Harvard Univ, Sch Med, Dept Med, Diabet Unit, Boston, MA USA
关键词
D O I
10.1016/S0002-9343(02)01103-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PURPOSE: Cardiovascular disease is the leading cause of death in patients with type 2 diabetes. We compared hyperglycemia management with the management of the cardiovascular disease risk factors hypertension and hypercholesterolemia in a cohort of type 2 diabetes patients. SUBJECTS AND METHODS: We randomly selected 601 patients with type 2 diabetes seen at the outpatient practices of all academic medical center and assessed the care they received during an 18-month period. we compared proportions of patients who had hemoglobin A(1c) (HbA(1c)) levels, blood pressure, or total cholesterol levels measured; who had been prescribed any drug therapy if HbA(1c) levels, systolic blood pressure, or low-density lipoprotein (LDL) cholesterol levels exceeded recommended treatment goals; and who had been prescribed greater-than-starting-close therapy if these values were above those of treatment goals. Results: Patients were less likely to have cholesterol levels (76%, n = 455) measured than HbA(1c) (92%, n = 552) levels or blood pressure (99%, n = 595; P <0.0001 for either comparison). The proportion of patients that received any drug therapy was greater for above-goal HbA(1c) (92%, n = 348) than for above-goal systolic blood pressure (78%, n = 274) or LDL cholesterol (38%, n = 82; P <0.0001 for each comparison). Similarly, patients whose HbA(1c) levels were above the treatment goal (80%, n = 302) were more likely to receive greater-than-starting-dose therapy, compared with those who had above-goal systolic blood pressure (62%, n = 218) and LDL cholesterol levels (13%, n = 28, P <0.0001). CONCLUSION: In this cohort, hypercholesterolemia and hypertension were managed less aggressively than was hyperglycemia. Given the prevalence of cardiovascular disease in patients with Type 2 diabetes, increased screening for hypercholesterolemia and more aggressive drug therapy for hypercholesterolemia and hypertension are needed.
引用
收藏
页码:603 / 609
页数:7
相关论文
共 48 条
[1]   Evaluating hypertension control in a managed care setting [J].
Alexander, M ;
Tekawa, I ;
Hunkeler, E ;
Fireman, B ;
Rowell, R ;
Selby, JV ;
Massie, BM ;
Cooper, W .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (22) :2673-2677
[2]   COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].
ALTMAN, R ;
CARRERAS, L ;
DIAZ, R ;
FIGUEROA, E ;
PAOLASSO, E ;
PARODI, JC ;
CADE, JF ;
DONNAN, G ;
EADIE, MJ ;
GAVAGHAN, TP ;
OSULLIVAN, EF ;
PARKIN, D ;
RENNY, JTG ;
SILAGY, C ;
VINAZZER, H ;
ZEKERT, F ;
ADRIAENSEN, H ;
BERTRANDHARDY, JM ;
BRAN, M ;
DAVID, JL ;
DRICOT, J ;
LAVENNEPARDONGE, E ;
LIMET, R ;
LOWENTHAL, A ;
MORIAU, M ;
SCHAPIRA, S ;
SMETS, P ;
SYMOENS, J ;
VERHAEGHE, R ;
VERSTRAETE, M ;
ATALLAH, A ;
BARNETT, H ;
BATISTA, R ;
BLAKELY, J ;
CAIRNS, JA ;
COTE, R ;
CROUCH, J ;
EVANS, G ;
FINDLAY, JM ;
GENT, M ;
LANGLOIS, Y ;
LECLERC, J ;
NORRIS, J ;
PINEO, GF ;
POWERS, PJ ;
ROBERTS, R ;
SCHWARTZ, L ;
SICURELLA, J ;
TAYLOR, W ;
THEROUX, P .
BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100
[3]   LONG-TERM GLYCEMIC CONTROL RELATES TO MORTALITY IN TYPE-II DIABETES [J].
ANDERSSON, DKG ;
SVARDSUDD, K .
DIABETES CARE, 1995, 18 (12) :1534-1543
[4]  
[Anonymous], 1991, JAMA, V265, P3255
[5]  
[Anonymous], 1993, DIABETES CARE, V16, P828
[6]  
[Anonymous], 1994, DIABETES CARE, V17, P616
[7]   Does hyperglycemia really cause coronary heart disease? [J].
BarrettConnor, E .
DIABETES CARE, 1997, 20 (10) :1620-1623
[8]   Prevalence of patients reaching the targets of good control in normal clinical practice - A cohort-based study in type 2 diabetes [J].
Bo, S ;
Cavallo-Perin, P ;
Gentile, L .
DIABETES CARE, 1999, 22 (12) :2092-2092
[9]   CHANGE AND CORRELATES OF CHANGE IN HIGH AND LOW-DENSITY LIPOPROTEIN CHOLESTEROL AFTER 6 YEARS - A PROSPECTIVE-STUDY [J].
CRIQUI, MH ;
FRANKVILLE, DD ;
BARRETTCONNOR, E ;
KLAUBER, MR ;
HOLDBROOK, MJ ;
TURNER, JD .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1983, 118 (01) :52-59
[10]   Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension [J].
Curb, JD ;
Pressel, SL ;
Cutler, JA ;
Savage, PJ ;
Applegate, WB ;
Black, H ;
Camel, G ;
Davis, BR ;
Frost, PH ;
Gonzalez, N ;
Guthrie, G ;
Oberman, A ;
Rutan, GH ;
Stamler, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (23) :1886-1892